ORBIMED ADVISORS LLC - Director, 10%+ Owner at Corvus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
CRVS on Nasdaq
All Insider Reports
All Insider Reports

ORBIMED ADVISORS LLC - trading volume in the past year for Corvus Pharmaceuticals, Inc.

Holdings reported by ORBIMED ADVISORS LLC for Corvus Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7,165,006 $29,796,393 $4.16 27 Jun 2025 Indirect
Common Warrants (right to buy) 0 27 Jun 2025 Indirect Common Stock

Transactions reported by ORBIMED ADVISORS LLC for Corvus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.